Antimicrobial Resistance and Infection Control · 2019 · 17 citations · 24 references
PharmacyClinical SciencesInfectious DiseasesAntimicrobial PharmacotherapyAntimicrobial StewardshipMedical MicrobiologyHealthcare-associated InfectionsHospital Antimicrobial StewardshipNosocomial Infection EpidemiologyNosocomial InfectionsClinical Score EvaluationEmpiric Antibiotic TherapyHospital-acquired Bloodstream InfectionMultidrug-resistant OrganismsMultidrug-resistant PathogensNosocomial Bacterial InfectionsNosocomial Bloodstream InfectionsNosocomial Pneumonia
Background: The recommendations of learned societies mention risk factors for the presence of multidrug resistant bacteria in hospital-acquired infections, but they do not propose a scoring system to guide empiric antibiotic therapy. Our study was aimed at developing a simple score for predicting "the presence of bacteria requiring carbapenem treatment" in ICU-acquired bloodstream infection and pneumonia. Methods: Between December 2011 and January 2015, we conducted a retrospective study using a prospectively collected French database of nosocomial infections in the polyvalent intensive care unit of a French university hospital. All patients with ICU-acquired bloodstream infection or pneumonia were included in the study. Bivariate and multivariate analyses were performed to develop the CarbaSCORE, and this score was internally validated. Results: In total, 338 patients were analyzed, including 27 patients requiring carbapenem treatment. The CarbaSCORE was composed of four criteria: "presence of bloodstream infection" (as opposed to pneumonia) scored 2 points, "chronic hemodialysis" scored 4 points, "travel abroad in the last 6 months" scored 5 points, and "MDR-colonization or prior use of a β-lactam of class ≥ 3" scored 6 points. Internal validation by bootstrapping showed an area under the receiver operating characteristic curve of 0.81 [0.73-0.89]. Sensitivity was 96% at the 6-point threshold and specificity was 91% at the 9-point threshold. Conclusions: The CarbaSCORE is a simple and efficient score for predicting the presence of bacteria requiring carbapenem treatment. Further studies are needed to test this score before it can be used in practice.
24
pROC: an open-source package for R and S+ to analyze and compare ROC curves
Xavier Robin, Natacha Turck, Alexandre Hainard et al. · BMC Bioinformatics · 2011 · 14K citations · Full text
André C. Kalil, Mark L. Metersky, Michael Klompas et al. · Clinical Infectious Diseases · 2016 · 3.9K citations · Full text
Antoní Torres, Michael S. Niederman, Jean Chastre et al. · European Respiratory Journal · 2017 · 1.4K citations · Full text
Jérôme Pugin, R Auckenthaler, Nabil Mili et al. · American Review of Respiratory Disease · 1991 · 1.1K citations